Schroder Investment Management Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-640,313	Closed	-$7.39M	–	1639
2020 Q4	$7.39M	Buy	640,313 +5,322	+0.8%	+$61.8K	0.01%	705
2020 Q3	$6.43M	Buy	634,991 +14,127	+2%	+$173K	0.01%	682
2020 Q2	$8.16M	Sell	620,864 -11,959	-2%	-$124K	0.01%	599
2020 Q1	$4.9M	Buy	632,823 +22,633	+4%	+$341K	0.01%	673
2019 Q4	$12.6M	Buy	610,190 +37,382	+7%	+$630K	0.02%	593
2019 Q3	$7.97M	Buy	572,808 +3,932	+0.7%	+$46.7K	0.01%	667
2019 Q2	$7M	Buy	568,876 +70,468	+14%	+$813K	0.01%	641
2019 Q1	$6.22M	Sell	498,408 -57,943	-10%	-$774K	0.01%	662
2018 Q4	$6.3K	Buy	556,351 +70,621	+15%	+$1.11M	0.01%	638
2018 Q3	$9.09M	Sell	485,730 -16,612	-3%	-$382K	0.02%	617
2018 Q2	$12.7M	Sell	502,342 -10,135	-2%	-$263K	0.02%	561
2018 Q1	$11.5M	Sell	512,477 -4,504	-0.9%	-$110K	0.02%	578
2017 Q4	$12.9M	Buy	516,981 +89,806	+21%	+$2.2M	0.02%	594
2017 Q3	$10.2M	Sell	427,175 -82,252	-16%	-$1.93M	0.02%	624
2017 Q2	$10.5M	Buy	509,427 +115,413	+29%	+$2.4M	0.02%	596
2017 Q1	$10.7M	Sell	394,014 -196,764	-33%	-$4.02M	0.02%	597
2016 Q4	$11.2M	Buy	590,778 +259,248	+78%	+$4.95M	0.02%	594
2016 Q3	$6.48M	Hold	331,530	–	–	0.01%	695
2016 Q2	$4.96M	Hold	331,530	–	–	0.01%	727
2016 Q1	$2.98M	Sell	331,530 -138,670	-29%	-$1.68M	0.01%	768
2015 Q4	$9.06M	Buy	470,200 +81,500	+21%	+$1.42M	0.02%	642
2015 Q3	$5.78M	Buy	388,700 +23,000	+6%	+$540K	0.01%	713
2015 Q2	$7.61M	Buy	365,700 +100,800	+38%	+$2.03M	0.02%	682
2015 Q1	$5.93M	Buy	264,900 +4,900	+2%	+$113K	0.01%	735
2014 Q4	$5.25M	Buy	+260,000	New	+$4.71M	0.01%	778

Other funds holding FLXN